Enrolling By Invitation NA INTERVENTIONAL 1-arm NCT07222605

Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device (MemorEM)

Research Study Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

Sponsor: NeuroEM Therapeutics, Inc.

Conditions Alzheimer Disease Cortico Basal Degeneration Dementia Frontotemporal Dementia Neurological Diseases or Conditions Parkinson Disease Posterior Cortical Atrophy (PCA)

Interventions MemorEM

Updated 3 times since 2025 Last updated: Feb 3, 2026 Started: Dec 1, 2025 Primary completion: Dec 15, 2027 Completion: Dec 15, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alzheimer Disease and Cortico Basal Degeneration and is currently ongoing. NeuroEM Therapeutics, Inc. leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Feb 2026 — Present [monthly]

Enrolling By Invitation NA

Status: Withheld → Enrolling By Invitation · Phase: None → NA
Jan 2026 — Feb 2026 [monthly]

Withheld
Nov 2025 — Jan 2026 [monthly]

Withheld

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeuroEM Therapeutics, Inc.
eQ8Health Corporation d/b/a CareONE Concierge

Data source: eQ8Health Corporation d/b/a CareONE Concierge

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States